[CAS NO. 198470-84-7]  Parecoxib

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [198470-84-7]

Distributor
Catalog
SLK-S4656
Brand
Selleck
CAS
198470-84-7

DESCRIPTION [198470-84-7]

Overview

MDLMFCD25976408
Molecular Weight370.42
Molecular FormulaC19H18N2O4S
SMILESCC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(S(NC(CC)=O)(=O)=O)C=C3

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.6996 mL13.4982 mL26.9964 mL
5 mM0.5399 mL2.6996 mL5.3993 mL
10 mM0.2700 mL1.3498 mL2.6996 mL
50 mM0.0540 mL0.2700 mL0.5399 mL

Description

Parecoxib (SC-69124, Valus-P, Vorth-P) is a selective inhibitor.

Targets

COX2 [1]

In vivo

Parecoxib, a selected cyclooxygenase-2 inhibitor, ameliorates neurologic deficits in the behavior studies and brain damage, including neuronal death, and brain edema in the MCP-1 and NeuN immunostaining in rats subjected to SAH(Subarachnoid Hemorrhage). Parecoxib is able to reduce early COX2 expression via inhibiting cJNK (p55) expression (dose-dependently), reduce IL-1β, IL-6 and MCP-1( at 2000 ug/kg/day at the time point of 24hr and 72hr after the induction of SAH), IL-8 (of the dosage of 2000 ug/kg/day at 24hr after the induction of SAH), and also reduce cleaved caspase-1 (at 1000 and 2000 ug/kg/day) and Caspase-9a (at 2000 ug/kg/day). Parecoxib reduces the NMDAR-1, and NMDAR-2a (at 1000 and 2000 ug/kg) after the induction of SAH.


Synonyms

Propanamide, N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-
N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanamide
Parecoxib
SC 69124
Vorth-P
Valus-P
Xapit